Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2016 - 2025)

Oramed Pharmaceuticals filings provide 8 years of Asset Utilization Ratio readings, the most recent being 0.01 for Q4 2025.

  • Quarterly Asset Utilization Ratio changed N/A to 0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, changed N/A year-over-year, with the annual reading at 0.01 for FY2025, N/A changed from the prior year.
  • Asset Utilization Ratio hit 0.01 in Q4 2025 for Oramed Pharmaceuticals, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.05 in Q3 2021 and bottomed at 0.01 in Q4 2023.
  • Average Asset Utilization Ratio over 4 years is 0.02, with a median of 0.02 recorded in 2022.
  • Peak annual rise in Asset Utilization Ratio hit 31.65% in 2023, while the deepest fall reached 66.92% in 2023.
  • Oramed Pharmaceuticals' Asset Utilization Ratio stood at 0.05 in 2021, then tumbled by 60.53% to 0.02 in 2022, then crashed by 66.92% to 0.01 in 2023, then soared by 49.28% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).